- Report
- March 2026
- 144 Pages
Global
From €3635EUR$3,999USD£3,135GBP
- Report
- May 2026
- 180 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2026
- 180 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- July 2025
- 236 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- October 2025
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- October 2025
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- October 2025
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- August 2025
- 150 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- March 2026
- 144 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- October 2025
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- January 2026
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- October 2025
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- February 2026
- 95 Pages
Global
From €3500EUR$4,125USD£3,124GBP
- Report
- November 2025
- 150 Pages
Global
From €4408EUR$4,850USD£3,802GBP
- Report
- May 2026
- 500 Pages
Global
From €4540EUR$4,995USD£3,915GBP
- Report
- May 2026
- 150 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- October 2025
- 92 Pages
Global
From €4408EUR$4,850USD£3,802GBP
- Report
- February 2026
- 200 Pages
United States
From €2718EUR$2,990USD£2,344GBP
- Report
- February 2026
- 150 Pages
United States
From €4408EUR$4,850USD£3,802GBP
- Report
- February 2026
- 89 Pages
United States
From €2590EUR$2,850USD£2,234GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more